Leerink, Piper Sandler, Guggenheim and LifeSci Capital are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Abivax announces $400M ADS offering
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Trump announces tariff deal with Japan, AT&T reports Q2 beat: Morning Buzz
- Abivax price target raised to $101 from $45 at LifeSci Capital
- Abivax upgraded to Overweight from Equal Weight at Morgan Stanley